These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2974527)

  • 21. The tumorigenicity diversification in human embryonic kidney 293 cell line cultured in vitro.
    Shen C; Gu M; Song C; Miao L; Hu L; Liang D; Zheng C
    Biologicals; 2008 Jul; 36(4):263-8. PubMed ID: 18378163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoplastic transformation of a human keratinocyte cell line by the v-fos oncogene.
    Lee MS; Yang JH; Salehi Z; Arnstein P; Chen LS; Jay G; Rhim JS
    Oncogene; 1993 Feb; 8(2):387-93. PubMed ID: 8426745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High c-myc amplification level contributes to the tumorigenic phenotype of the human breast carcinoma cell line SW 613-S.
    Lavialle C; Modjtahedi N; Cassingena R; Brison O
    Oncogene; 1988 Sep; 3(3):335-9. PubMed ID: 3060796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double-stranded RNA-dependent protein kinase, PKR, down-regulates CDC2/cyclin B1 and induces apoptosis in non-transformed but not in v-mos transformed cells.
    Dagon Y; Dovrat S; Vilchik S; Hacohen D; Shlomo G; Sredni B; Salzberg S; Nir U
    Oncogene; 2001 Dec; 20(56):8045-56. PubMed ID: 11781817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumorigenic conversion resulting from inhibition of apoptosis in a nontumorigenic HeLa-derived hybrid cell line.
    Oka K; Qi B; Yutsudo M
    Cancer Res; 1999 Apr; 59(8):1816-9. PubMed ID: 10213483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of the tumorigenic phenotype with in vitro, but not in vivo, passaging of a novel series of human bronchial epithelial cell lines: possible role of an alpha 5/beta 1-integrin-fibronectin interaction.
    Schiller JH; Bittner G
    Cancer Res; 1995 Dec; 55(24):6215-21. PubMed ID: 8521416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of malignancy by the 3' untranslated regions of ribonucleotide reductase R1 and R2 messenger RNAs.
    Fan H; Villegas C; Huang A; Wright JA
    Cancer Res; 1996 Oct; 56(19):4366-9. PubMed ID: 8813126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transformation of human mammary epithelial cells by oncogenic retroviruses.
    Clark R; Stampfer MR; Milley R; O'Rourke E; Walen KH; Kriegler M; Kopplin J; McCormick F
    Cancer Res; 1988 Aug; 48(16):4689-94. PubMed ID: 3293776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transformation of diploid human fibroblasts by DNA transfection with the v-sis oncogene.
    Fry DG; Milam LD; Maher VM; McCormick JJ
    J Cell Physiol; 1986 Aug; 128(2):313-21. PubMed ID: 3015989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of adeno-associated virus on transformation of NIH 3T3 cells by ras gene and on tumorigenicity of an NIH 3T3 transformed cell line.
    Katz E; Carter BJ
    Cancer Res; 1986 Jun; 46(6):3023-6. PubMed ID: 3009007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of specific transformation-associated proteins (TAPs) in two rat cell lines is closely related to the expression of the v-mos gene product of Moloney murine sarcoma virus (Mo-MSV).
    Li W; Bowen JM; Chan JC
    Intervirology; 1987; 28(1):50-6. PubMed ID: 2828268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonal analysis of the expression of multiple transformation phenotypes and tumorigenicity by morphologically transformed 10T1/2 cells.
    Smith GJ; Bell WN; Grisham JW
    Cancer Res; 1993 Feb; 53(3):500-8. PubMed ID: 8425183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recognition of mos-related proteins with an antiserum to a peptide of the v-mos gene product.
    Gallick GE; Sparrow JT; Singh B; Maxwell SA; Stanker LH; Arlinghaus RB
    J Gen Virol; 1985 May; 66 ( Pt 5)():945-55. PubMed ID: 2987403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of nude mice with the host species for evaluation of the tumorigenicity of guinea pig and hamster cells transformed in vitro by chemical carcinogens.
    Evans CH; DiPaolo JA
    Cancer Res; 1976 Jan; 36(1):128-31. PubMed ID: 1247991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential transformation of C3H10T1/2 cells by v-mos: sequential expression of transformation parameters.
    van der Hoorn FA; Müller V
    Mol Cell Biol; 1985 Sep; 5(9):2204-11. PubMed ID: 3016522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of dexamethasone-induced metallothionein expression and cis-diamminedichloroplatinum(II) resistance by v-mos.
    Basu A; Lazo JS
    Cancer Res; 1991 Feb; 51(3):893-6. PubMed ID: 1824827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A mos oncogene-containing retrovirus, myeloproliferative sarcoma virus, transforms rat thyroid epithelial cells and irreversibly blocks their differentiation pattern.
    Fusco A; Portella G; Di Fiore PP; Berlingieri MT; Di Lauro R; Schneider AB; Vecchio G
    J Virol; 1985 Oct; 56(1):284-92. PubMed ID: 2993656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The P55 protein affected by v-mos expression is vimentin.
    Singh B; Goldman R; Hutton L; Herzog NK; Arlinghaus RB
    J Virol; 1987 Nov; 61(11):3625-9. PubMed ID: 2822968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of a collagen gene promoter by the product of viral mos oncogene.
    Schmidt A; Setoyama C; de Crombrugghe B
    Nature; 1985 Mar 21-27; 314(6008):286-9. PubMed ID: 2984572
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production and characterization of a monoclonal antibody to the v-mos oncogene protein.
    Ishikawa K; Kurata N; Aoki H; Kato T; Marunouchi T
    Hybridoma; 1991 Jun; 10(3):357-68. PubMed ID: 1833309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.